208 related articles for article (PubMed ID: 27874212)
1. Dorsal column myelopathy after intrathecal chemotherapy for leukemia.
Pinnix CC; Chi L; Jabbour EJ; Milgrom SA; Smith GL; Daver N; Garg N; Cykowski MD; Fuller G; Cachia D; Kamiya-Matsuoka C; Woodman K; Dinardo C; Jain N; Kadia TM; Pemmaraju N; Ohanian M; Konopleva M; Kantarjian HM; Dabaja BS
Am J Hematol; 2017 Feb; 92(2):155-160. PubMed ID: 27874212
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate-induced myelopathy mimicking subacute combined degeneration of the spinal cord.
Gosavi T; Diong CP; Lim SH
J Clin Neurosci; 2013 Jul; 20(7):1025-6. PubMed ID: 23647709
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate myelopathy after intrathecal chemotherapy: a case report.
Murata KY; Maeba A; Yamanegi M; Nakanishi I; Ito H
J Med Case Rep; 2015 Jun; 9():135. PubMed ID: 26055509
[TBL] [Abstract][Full Text] [Related]
4. Myelopathy mimicking subacute combined degeneration in a Down syndrome patient with methotrexate treatment for B lymphoblastic leukemia: report of an autopsy case.
Satomi K; Yoshida M; Matsuoka K; Okita H; Hosoya Y; Shioda Y; Kumagai MA; Mori T; Morishita Y; Noguchi M; Nakazawa A
Neuropathology; 2014 Aug; 34(4):414-9. PubMed ID: 24661121
[TBL] [Abstract][Full Text] [Related]
5. Progressive myelopathy mimicking subacute combined degeneration after intrathecal chemotherapy.
Yi Y; Kang HJ; Shin HY; Kim K
J Child Neurol; 2015 Feb; 30(2):246-9. PubMed ID: 24659737
[TBL] [Abstract][Full Text] [Related]
6. Myelopathy following intrathecal chemotherapy in adults: a single institution experience.
Cachia D; Kamiya-Matsuoka C; Pinnix CC; Chi L; Kantarjian HM; Cortes JE; Daver N; Woodman K
J Neurooncol; 2015 Apr; 122(2):391-8. PubMed ID: 25666482
[TBL] [Abstract][Full Text] [Related]
7. Spinal Cord Toxicity from Intrathecal Chemotherapy: A Case with Clinicopathologic Correlation.
Dornbos D; Elder JB; Otero JJ; Baiocchi RA; Slone HW; Puduvalli VK; Giglio P
World Neurosurg; 2019 Aug; 128():381-384. PubMed ID: 31128312
[TBL] [Abstract][Full Text] [Related]
8. Myelopathy associated with intrathecal methotrexate.
Rodrigues PGB; Lima TT; Duarte FB; Nóbrega PR
Pract Neurol; 2022 Apr; 22(2):141-144. PubMed ID: 34716225
[TBL] [Abstract][Full Text] [Related]
9. Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
Counsel P; Khangure M
Clin Radiol; 2007 Feb; 62(2):172-6. PubMed ID: 17207701
[No Abstract] [Full Text] [Related]
10. Ascending myelopathy after intrathecal methotrexate.
Chiu YH; Yang E; Chen YC
Kaohsiung J Med Sci; 2021 Nov; 37(11):1018-1019. PubMed ID: 34292665
[No Abstract] [Full Text] [Related]
11. Myelopathy due to intrathecal chemotherapy: report of six cases.
Bay A; Oner AF; Etlik O; Yilmaz C; Caksen H
J Pediatr Hematol Oncol; 2005 May; 27(5):270-2. PubMed ID: 15891563
[TBL] [Abstract][Full Text] [Related]
12. [Spinal subacute combined degeneration after intrathecal chemotherapy. Report of two cases].
Cartier R L; Parra V J; Puga B; Cardemil D
Rev Med Chil; 2018 Jun; 146(6):802-807. PubMed ID: 30148913
[TBL] [Abstract][Full Text] [Related]
13. MR findings of intrathecal chemotherapy-related myelopathy in two cases: mimicker of subacute combined degeneration.
Lu CH; Yao M; Liu HM; Chen YF
J Neuroimaging; 2007 Apr; 17(2):184-7. PubMed ID: 17441843
[TBL] [Abstract][Full Text] [Related]
14. [Necrotizing myelopathy after intrathecal methotrexate].
Sanhes L; Delmer A; Zittoun R
Presse Med; 1997 May 3-10; 26(15):719. PubMed ID: 9183374
[No Abstract] [Full Text] [Related]
15. Dorsal column myelopathy following intrathecal chemotherapy for acute lymphoblastic leukemia.
Joseph PJ; Reyes MR
J Spinal Cord Med; 2014 Jan; 37(1):107-13. PubMed ID: 24090227
[TBL] [Abstract][Full Text] [Related]
16. Rechallenging With Intrathecal Methotrexate After Developing Subacute Neurotoxicity in Children With Hematologic Malignancies.
Badke C; Fleming A; Iqbal A; Khilji O; Parhas S; Weinstein J; Morgan E; Hijiya N
Pediatr Blood Cancer; 2016 Apr; 63(4):723-6. PubMed ID: 26681571
[TBL] [Abstract][Full Text] [Related]
17. Acute ascending motoric paraplegia following intrathecal chemotherapy for treatment of acute lymphoblastic leukemia in children: case reports and review of the literature.
Rolf N; Boehm H; Kaindl AM; Lauterbach I; Suttorp M
Klin Padiatr; 2006; 218(6):350-4. PubMed ID: 17080338
[TBL] [Abstract][Full Text] [Related]
18. A rare complication of intrathecal methotrexate in a child with acute lymphoblastic leukemia.
Tufekci O; Yilmaz S; Karapinar TH; Gozmen S; Cakmakci H; Hiz S; Irken G; Oren H
Pediatr Hematol Oncol; 2011 Sep; 28(6):517-22. PubMed ID: 21699468
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal methotrexate induces focal cognitive deficits and increases cerebrospinal fluid homocysteine.
Li Y; Vijayanathan V; Gulinello M; Cole PD
Pharmacol Biochem Behav; 2010 Jun; 95(4):428-33. PubMed ID: 20332001
[TBL] [Abstract][Full Text] [Related]
20. Neurotoxicity of intrathecal methotrexate: MR imaging findings.
Sandoval C; Kutscher M; Jayabose S; Tenner M
AJNR Am J Neuroradiol; 2003 Oct; 24(9):1887-90. PubMed ID: 14561622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
